Chapter 2. The Rationale for Evidence-Based Dermatology

  1. Hywel Williams MSC, PhD, FRCP Professor Dermato-Epidemiology Co-ordinating Editor
  1. Hywel Williams MSC, PhD, FRCP Professor Dermato-Epidemiology Co-ordinating Editor3 and
  2. Michael Bigby MD Associate Professor of Dermatology1,2

Published Online: 14 JAN 2009

DOI: 10.1002/9781444300161.ch2

Evidence-Based Dermatology, Second Edition

Evidence-Based Dermatology, Second Edition

How to Cite

Williams, H. and Bigby, M. (2008) The Rationale for Evidence-Based Dermatology, in Evidence-Based Dermatology, Second Edition (ed H. Williams), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300161.ch2

Editor Information

  1. Centre of Evidence-Based Dermatology, Nottingham University Hospital NHS Trust, Queen's Medical Centre, Nottingham, UK

Author Information

  1. 1

    Department of Dermatology, Harvard Medical School, Boston, MA, USA

  2. 2

    Beth Israel, Deaconess Medical Center, Boston, MA, USA

  3. 3

    Centre of Evidence-Based Dermatology, Nottingham University Hospital NHS Trust, Queen's Medical Centre, Nottingham, UK

Publication History

  1. Published Online: 14 JAN 2009
  2. Published Print: 11 APR 2008

ISBN Information

Print ISBN: 9781405145183

Online ISBN: 9781444300161

SEARCH

Keywords:

  • evidence-based dermatology (EBD) rationale;
  • randomized clinical trial (RCT);
  • “designer” drugs - topical tazarotene;
  • evidence-based dermatology and five steps;
  • critically appraised topic (CAT);
  • EBD process - starts and ends with patients;
  • developing structured question;
  • biomedical information publication

Summary

This chapter contains sections titled:

  • What is evidence-based dermatology?

  • The process of evidence-based dermatology

  • Conclusions

  • References